Objective. To study the prevalence of echocardiographic abnormality and pulmonary hypertension in an unselected population of patients with rheumatoid arthritis (RA).
Rheumatoid arthritis (RA) is a common condition
Doppler echocardiography has been proven to be a reliable non-invasive method for detecting pulmonary affecting 1% of the white population and over 5% of people over the age of 65 yr. Amongst many other extrahypertension in chronic lung disease [4, 5] and systemic sclerosis [6 ] . The aim of this study was to determine the articular features, several forms of cardiac involvement have been described in RA, most commonly pericarditis prevalence of echocardiographic abnormalities and raised pulmonary artery pressure in a district general and pericardial effusion. Pulmonary hypertension has also been described in RA patients. This is usually a hospital population of patients with RA. All patients were evaluated with full pulmonary function tests, chest result of RA-associated lung disease [1] . Isolated case reports of primary pulmonary hypertension have been radiographs and high-resolution computed tomography (HRCT ) to determine whether raised pulmonary artery published [2] . Primary pulmonary hypertension is often clinically silent until well advanced. It has a very poor pressure is secondary to lung disease. prognosis and a median survival of only 2-3 yr [3] . Secondary pulmonary hypertension progresses more slowly than the primary form. Treatment initially needs Methods to be directed at the underlying cause. The presence of pulmonary hypertension secondary to lung disease One hundred and forty-six consecutive patients attending the rheumatology outpatient departments of implies a poor prognosis.
St Helens and Knowsley Hospitals NHS Trust with an established diagnosis of RA, as defined by the American provided informed consent. In view of the radiation exposure involved in the study, patients were excluded venous pressure to the estimate of the trans-tricuspid gradient [7] . if they were pregnant or planning a pregnancy.
The ejection fraction was calculated as follows [8] of these patients the lung disease was sufficiently severe to cause significant volume loss (as defined above, under found that the maximum estimated pulmonary artery pressure was 24 mmHg.
Significant lung disease) on pulmonary function testing. Clinically, 6% of the RA population studied had pulTo assess the diagnostic validity of the results of the echocardiogram, a control group for echocardiogram monary hypertension that was secondary to lung disease. The pulmonary artery pressures are shown in Table 3 , readings was incorporated into the study. One hundred and forty-three echocardiography examinations perand the ECG findings that were found most frequently in patients with pulmonary hypertension are shown formed in the cardiorespiratory department of St Helens and Knowsley Trust Hospitals were recorded prospectin Table 4 . The clinical features of the patients with primary ively. The patients were adults (48% female, age range 16-88 yr, average age 62 yr) referred for assessment of pulmonary hypertension were compared with those of RA patients who had a pulmonary artery pressure below potential or known heart disease. Patients with RA were excluded. Echocardiography was undertaken with the 30 mmHg. The findings are shown in Table 5 . No significant difference was found between the two RA same Hewlett-Packard echocardiogram by the same senior technician who performed the echocardiography groups when sex, disease duration, disease severity, smoking and corticosteroid treatment were compared. in the patients with RA.
The acute-phase response, as assessed by plasma viscosity and C-reactive protein measured at the time of
Results
clinical evaluation, did not differ significantly between the groups. All the patients with primary pulmonary All RA patients hypertension were recorded as taking NSAIDs, and 94% One hundred and forty-six RA patients underwent all of the patients with RA whose PASP was below the investigations. One hundred and eleven (76%) 30 mmHg were taking NSAIDs; again this was not patients had sufficient tricuspid regurgitation visible for statistically significant. their pulmonary artery pressures to be assessed by
We subsequently investigated the patients with primDoppler echocardiography. No patients had a visibly ary pulmonary hypertension for the presence of antielevated jugular venous pressure. Five patients had cardiolipin antibodies, but none of the patients tested calcification of the mitral valve but no patients had was found to have a significantly elevated concentramitral stenosis. No patients had right ventricular dilatation (normal range, IgG 0-9 GPL U/ml, IgM 0-4 tion or hypertrophy. The structural findings for the RA MPL U/ml ). patients are listed in Table 2 .
Pulmonary artery pressure in the control group RA patients with raised pulmonary artery pressure ( HRCT was also performed on these patients, and it 40-50 mmHg 12 (8) 0 identified early fibrosing alveolitis in an additional six alveolitis is unlikely to be at a stage to be causing secondary pulmonary hypertension. Whether or not pulmonary hypertension. It certainly suggests that the left-sided heart abnormalities they found in their populafibrosing alveolitis on HRCT predicts the rate at which pulmonary hypertension progresses is yet to be tion were not causing significant cardiac disease. It is also interesting to postulate that if they had no patients determined.
Doppler echocardiography is both sensitive and with PASP above 30 mmHg, the selection bias between their study group and ours may explain the cause of specific for the diagnosis of pulmonary hypertension [6, 18] . By taking a definition of pulmonary hypertension pulmonary hypertension in our patients. Our control population represents pulmonary artery as a PASP of 30 mmHg or greater, we will have underdiagnosed the number of patients with pulmonary hyperpressure readings in a non-rheumatoid population undergoing echocardiography on the same equipment tension. This is supported by the observation that patients with right-heart strain patterns on ECG had by the same technician. Obviously, these readings do not represent the normal population and referral bias estimated pulmonary artery pressures of at least 24 mmHg.
explains the high prevalence of cardiac disease. We will have potentially overestimated the number of patients The relative lack of ECG changes has been noted in studies with right-heart catheterization. This occurs parwith primary pulmonary hypertension, as the control group was not screened for lung disease or other known ticularly in secondary pulmonary hypertension [23] . P-wave changes are found in 20% of patients with causes of pulmonary hypertension. Despite these factors, the rheumatoid population still had a significantly higher pulmonary hypertension and right-sided strain patterns in 70% [24] . In the two patients with severe pulmonary prevalence of raised pulmonary artery pressure. A limitation of our study is that we did not assess hypertension, ECGs showed left bundle branch block patterns masking the typical changes of right-sided heart pulmonary artery pressure by echocardiography in normal age-and sex-matched controls. A study of 20 predominance.
It has been noted recently that RA patients have an normal healthy adults by Vachiery et al. [17] with Doppler echocardiography found that the maximum increased number of abnormalities related to the function of the left ventricle [19, 25] . The frequency of these estimated pulmonary artery pressure was 24 mmHg. As Doppler echocardiography and cardiac catheterizabnormalities is significantly higher than that in control populations when patients with diabetes mellitus, ation have been reported to have a correlation of between 0.89 and 0.97 in cardiac causes of pulmonary myocardial infarction and hypertension are excluded.
Impairment of left ventricular function can cause hypertension [10, 11], we have not undertaken catheterization of our RA patients. In 1998 the first case elevation of pressure on the left atrium and raise pulmonary artery pressure. It would seem unlikely that this report appeared in which echocardiographic estimation of pulmonary artery pressure was found to be incorrect is the cause of the raised pulmonary artery pressure, as patients with a reduced left ventricular ejection fraction at the time of right-heart catheterization [26 ] . It would seem unlikely that, in a large study of RA patients that have been excluded.
When using a PASP of 30 mmHg as the cut-off point has identified 45 patients with raised PASP pressure, this is an aberrant finding. to compare the features of RA patients, we have not found an explanation for the raised pulmonary artery
We have identified mild pulmonary hypertension in RA patients. In these patients no significant symptoms, pressures. This may be because we have used a high threshold to diagnose pulmonary hypertension with signs, ECG or structural echocardiographic changes were apparent. Of course, this may be because we echocardiography; a PASP below 24 mmHg may well be more suitable for comparisons. The study would detected the disease at an early stage, but right-sided ECG abnormalities were detected at pulmonary artery certainly need to be extended to have sufficient power to ensure that a type II statistical error does not arise.
pressures of 24 mmHg and above in patients with severe lung disease. Bach et al. [4] also found that pulmonary To be certain that the degree of acute-phase response is not related to the development of pulmonary hypertenhypertension (>35 mmHg) secondary to emphysema was associated with right-sided structural abnormalities sion, serial measurements would be superior to a single reading at the time of assessment. visible on echocardiography. It is likely that an explanation of these differences in the cardiac response to raised The only RA study that has included pulmonary artery pressure, by Wislowska et al. [19] , did not record pulmonary artery pressure will be forthcoming only when we understand the pathogenesis of pulmonary a PASP above 35 mmHg. The paper is not focused on pulmonary hypertension and does not give the method hypertension in RA patients. Due to the physical limitations arising from arthritis, of determining PASP, the number of patients who had PASP readings and the reason for using a threshold RA patients present with shortness of breath as a result of cardiorespiratory disease at a later stage than the above 35 mmHg. We found that 19% of all the RA patients had PASP within the range 30-35 mmHg. It is normal population. Deaths that have been assumed previously to be due to ischaemic heart disease, because possible that this mild but definite pulmonary hypertension was recorded by Wislowska 
